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Abstract
Background: Clinical microbiology may direct decisions regarding hospitalization, isolation and anti-infective therapy, but it
is not effective at the time of early care. Point-of-care (POC) tests have been developed for this purpose.
Methods and Findings: One pilot POC-lab was located close to the core laboratory and emergency ward to test the proof of
concept. A second POC-lab was located inside the emergency ward of a distant hospital without a microbiology laboratory.
Twenty-three molecular and immuno-detection tests, which were technically undemanding, were progressively
implemented, with results obtained in less than four hours. From 2008 to 2010, 51,179 tests yielded 6,244 diagnoses.
The second POC-lab detected contagious pathogens in 982 patients who benefited from targeted isolation measures,
including those undertaken during the influenza outbreak. POC tests prevented unnecessary treatment of patients with
non-streptococcal tonsillitis (n=1,844) and pregnant women negative for Streptococcus agalactiae carriage (n=763). The
cerebrospinal fluid culture remained sterile in 50% of the 49 patients with bacterial meningitis, therefore antibiotic
treatment was guided by the molecular tests performed in the POC-labs. With regard to enterovirus meningitis, the mean
length-of-stay of infected patients over 15 years old significantly decreased from 2008 to 2010 compared with 2005 when
the POC was not in place (1.4361.09 versus 2.9162.31 days; p=0.0009). Altogether, patients who received POC tests were
immediately discharged nearly thrice as often as patients who underwent a conventional diagnostic procedure.
Conclusions: The on-site POC-lab met physicians’ needs and influenced the management of 8% of the patients that
presented to emergency wards. This strategy might represent a major evolution of decision-making regarding the
management of infectious diseases and patient care.
Citation: Cohen-Bacrie S, Ninove L, Nougaire `de A, Charrel R, Richet H, et al. (2011) Revolutionizing Clinical Microbiology Laboratory Organization in Hospitals
with In Situ Point-of-Care. PLoS ONE 6(7): e22403. doi:10.1371/journal.pone.0022403
Editor: Markus M. Heimesaat, Charite ´, Campus Benjamin Franklin, Germany
Received March 22, 2011; Accepted June 21, 2011; Published July 19, 2011
Copyright:  2011 Cohen-Bacrie et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the program Soutien aux Technologies Innovantes et Cou ˆteuses STIC 2006, French Ministry of Health, regarding the POC
activity for cerebrospinal fluid. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: Didier.raoult@gmail.com
Introduction
Health care policies are heterogeneous worldwide, but a global
effort is striving to achieve a higher value of care delivery. Current
strategies are designed to combine quality of care and cost con-
tainment [1,2]. With regard to medical biology, facilities were
generally reorganized into core laboratories in the United States
beginning in the 1990s [3,4], and this was supported by the
automation of tests [5,6]. European laboratories are currently
following the trend toward centralization of biomedical analyses
[7]. Although this organization is cost-effective, the distance from
the laboratories to the site of patient care and the batch processing
of clinical specimens make rapid turn-around times impossible
[3,6]. Consequently, microbiology laboratories are unable to
contribute to timely decision-making for most infectious diseases
[6-8], resulting in unnecessary treatment and hospitalization [9] as
well as the empiric use of antibiotics.
To resolve the time lag between test results and patient care, a
growing range of rapid diagnostic tests that can be performed at
the point of care (POC) has been implemented [10,11]. Although
most POC tests rely on immuno-chromatographic or agglutination
assays, miniaturization and full automation of molecular methods
allow for quicker real-time PCR-based detection of pathogens
using simplified procedures [10,12]. These tests address the need
to hospitalize patients, to isolate contagious individuals and to
initiate and focus anti-infective therapy. For example, the rapid
testing of Group B Streptococcus colonization in pregnant women at
delivery enables timely, focused prophylaxis of materno-fetal
infections [13,14].
In Marseilles, a core laboratory facility serving all five university
hospitals (3,500 beds) was adopted for economic purposes. Delays
of test results inherently increased as a consequence of the batch
processing of higher demand volumes and the geographical
distance from hospitals to the laboratory. Thus, a strategy was
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POC testing. This pilot ‘‘POC-lab’’, the la Timone POC-lab, was
located close to both a pediatric emergency department and our
core laboratory to evaluate feasibility. In May of 2008, a second
POC-lab was then implemented inside the emergency department
of the most distant hospital, Ho ˆpital Nord, which is an 800-bed
healthcare structure. This original strategy was retrospectively
evaluated over a period of three years. The purpose of our study
was not to assess the intrinsic performances of the methods, which
were validated elsewhere. Instead, the aim of our work was to
evaluate the practicability of a new process, its potential impact on




POC-labs were designed as autonomous structures running with
minimal dedicated material and reagents, and they were contained
in a single room. The sizes of the rooms were 18.8 m
2 in la
Timone and 18 m
2 in Ho ˆpital Nord (figure 1).
POC-lab staff
Both POC-labs were organized to run 24 hours per day with a
single operator, under the supervision of a medical microbiologist
who was on call. The technical staff performing the tests was
residents training in clinical microbiology in accordance with the
French legislation (ordonnance nu 2010-49 du 13 janvier 2010
relative a ` la biologie me ´dicale). Prior to working in the POC-labs,
they were given a half-day teaching course provided by a medical
microbiologist working in the core laboratory. The theoretical
aspects of POC testing were reviewed, including nonconformities,
principles of immuno-chromatographic tests (ICT), real-time PCR
assays and the necessity for controls and interpretation of results.
Five days of practical learning were required to learn all the
quality procedures necessary for safe and appropriate testing.
Written procedures illustrated with photos were also available on a
intranet system to provide the technical staff with constant access
to the instructions related to POC testing. A start menu gave
access to the panel of POC testing, the locations where reagents
were stored, detailed procedures for tests and pictures of test
results.
One of the medical microbiologists working in the core labo-
ratory was responsible for the medical validation of test results and
could be reached at any time. The results were reviewed once
daily in the morning. A weekly lab meeting was also prepared to
display POC week activity and results, including the number of
tests requested and the number and rate of positive results, using a
Microsoft Excel table. The results of molecular tests were then
compared on a weekly basis to the results of the tests performed in
the core laboratory, such as culture, serology and additional
molecular testing.
POC-lab tests and procedures
The tests and procedures that were implemented in POC-labs
were technically undemanding and included 13 immuno-
chromatographic tests (ICTs), 2 agglutination assays and 3 com-
mercially available and 5 laboratory-developed real-time PCR assays
(table S1). The specimens were processed as soon as they were
delivered, and the test turnaround time did not exceed 4 hours,
varying between 30 minutes and 3.5 hours according to the tests.
The laboratory-developed PCR assays were first tested in the
core laboratory before being implemented in the POC-labs. The
Figure 1. Layout of the POC-lab and equipment.
doi:10.1371/journal.pone.0022403.g001
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of primers and probes was performed using Primer3 software. The
sequences of primers and probes are detailed in Table S2. The
reference and clinical strains were used to set up the PCR
procedures (details in text S1); the methods were then evaluated in
clinical routine to validate the performances.
The ready-to-use mixes and amplification controls were
respectively prepared in the reagent preparation clean room and
the nucleic acid extraction room of the core laboratory and stored
at 220uC. The positive and negative amplification controls were
made with extracts from clinical specimens and nuclease-free
distilled water, respectively. The validity of every newly-prepared
batch of mixes and controls was checked; the positive controls
were validated if the amplification signal was observed within an
acceptable range (25–30 Ct). Consequently, the only steps the
POC-lab staff was required to perform to run PCRs were the
extraction step and the addition of fresh nucleic acid extracts. The
results were defined as valid if 1) the negative control did not
produce an amplification curve, and 2) the positive control
produced an amplification signal within an acceptable range. Post-
PCR manipulations were not performed in the POC-labs.
For the influenza tests, ICT was performed during the entire
study period. During the 2009 pandemic, the detection of the A/
H1N1 influenza virus was also performed by real-time RT-PCR in
POC-labs, which occurred from June 23 until the end of August,
as previously reported [15]. Afterwards, the burst of activity led to
the removal of the H1N1 PCR assay from POC-labs. However,
the extraction step was still performed in POC-labs, and the core
laboratory could then provide a definitive result in less than
24 hours.
Volume of POC demands and diagnoses
POC testing did not provide a substitute for the routine analyses
performed in the core laboratory because tests were requested at
the physicians’ convenience. Distinct laboratory request forms
were therefore created for POC and core lab testing. Each month,
we quantified both the number of POC tests ordered by physicians
as well as the test findings. The data were extracted using
InfoCentre software and sorted by Microsoft Excel software. The
complete list of patients admitted in the emergency department of
Ho ˆpital Nord in 2009 was extracted anonymously from the data
bank ORUPACA.
Outcomes resulting from POC testing
Four main outcomes were expected according to test results:
isolation of contagious patients, avoidance of unnecessary
hospitalization, avoidance of unnecessary treatment (prescription
of antiinfectious treatment avoided and/or reduced length of
antiinfectious treatment) and the focusing of anti-infective therapy.
Using this categorization, the number of theoretical outcomes
resulting from POC-lab testing was assessed by focusing on the
Ho ˆpital Nord POC-lab. In the case of tonsillitis, the avoidance of
empiric amoxicillin treatment was assessed using a 70-kg adult as a
reference (1 g twice daily for 6 days). In the case of enterovirus
meningitis, the mean length of the hospital stay of infected patients
during the study period from 2008 to 2010 was measured and
compared with that of infected patients during the 2005 outbreak
[16]. From 2008 to 2010, enterovirus was detected in POC-labs by
using the GeneXpert system (Cepheid, Sunnyvale, CA), whereas
in 2005, the diagnosis was performed in the core laboratory using
a laboratory-developed real-time RT-PCR assay [16]. To evaluate
the respective impact of POC testing on patient management for
bacterial meningitis, the number of diagnoses provided by POC
testing was compared with that provided by microscopic
examination and culture. For meningitis, testing requests that
were collected from both POC-labs were considered to obtain a
more representative sample of patients.
Statistics
All data were analyzed with EpiInfo software (version 3.5.1,
CDC, USA). Continuous variables were compared using analysis
of variance or, when the data were abnormally distributed, the
Mann-Whitney/Wilcoxon two-sample test. Proportions were com-
pared by using the table function of EpiInfo software. The Mantel
Haenszel test was used except when an expected cell value was less
than 5, so the Fisher exact test was used. Statistical significance
was defined as a p value ,0.05.
Ethical aspects
Following national regulations under the term of Biomedical
Research (Loi Huriet-Se ´rusclat), a patient’s signature at the
hospital entrance office authorizes all the samples taken during
hospitalization for diagnostic purposes to be accessible for research
without specific consent from the patient, excluding those for
human genetic research. Thus, ethics approval was not requested
according to the Loi Huriet-Se ´rusclat.
Results
Integration of POC-lab tests within the diagnosis process
A total of 51,179 test requests were collected, including 8,605,
26,055 and 16,519 requests in 2008, 2009 and 2010, respectively
(table S3). The la Timone and Ho ˆpital Nord POC-labs collected
57% and 43% of these tests, respectively. The highest demand
came from the emergency wards, with a smaller demand from the
pediatrics and infectious diseases departments. The emergency,
pediatrics and infectious diseases requests accounted for 73%,
10%, and 9% of the Ho ˆpital Nord POC-lab requests and 60%,
14% and 4% of the la Timone POC-lab requests, respectively. A
total of 6,244 positive results were provided, with 12% of the tests
that were performed resulting in a positive result.
Testing related to respiratory tract infections (as listed in table
S1) represented 78% of the overall demand. A burst of influenza
demands related to the A/H1N1 outbreak occurred in 2009 with
an early peak of diagnoses observed as early as August of 2009
(figure 2). From June 2009 through April of 2010, 1,075 tests out
of 10,609 demands were positive for the influenza A virus,
compared with 520 positive tests out of 3,491 demands from
November of 2008 through April of 2009 (86% of A influenza
virus). The diagnostic yields peaked at 15% in November 2009 in
comparison to the previous influenza epidemic, which peaked at
25% in January of 2009. Alternatively, the number of respiratory
syncytial virus diagnoses was stationary from 2008 to 2009
and from 2009 to 2010, regarding the period spreading from
November through April (522 and 506 diagnoses, respectively).
The demand related to meningitis resulted in 4,097 tests.
Enterovirus was the most frequently detected pathogen (234
diagnoses), with a peak of detection during summer and fall. A
bacterial pathogen was detected in 49 patients, and herpes simplex
virus-1/2 (HSV-1/2) was detected in six patients. For digestive
infections, 4,380 tests were prescribed and 756 diagnoses were
made, with rotavirus being the most frequently detected pathogen
(613 diagnoses). Intrapartum detection of S. agalactiae in vaginal
samples was positive in 16% of tested patients. With regard to HIV
infection, 11 positive patients were diagnosed among 869 serologic
tests, and 62% of those requests came from wards other than
obstetrics because indications were extended to blood exposure
accidents. In febrile patients returning from tropical countries,
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of these 223 diagnoses were for Plasmodium falciparum.
Impact of POC testing on patient management
The test results were subsequently sorted according to the
expected outcomes of patients that presented to the emergency
wards of the Ho ˆpital Nord. The Ho ˆpital Nord POC-lab detected a
transmissible agent in 982 patients (table 1). The POC strategy was
particularly crucial during the A/H1N1 influenza outbreak
because only 11% of 3,097 tested patients were positive, and
this avoided unnecessary isolation measures and treatment by
oseltamivir in most cases. Similarly, treatment with amoxicillin
might have been avoided for 1,844 of the 2,497 patients tested for
tonsillitis, as well as for 763 of the 913 women of unknown status
who were tested for S. agalactiae. A total of 11,064 days of empiric
amoxicillin treatment might have been avoided in patients with
negative Streptococcus pyogenes antigen tests and infectious mononu-
cleosis diagnoses. In cases of bacterial meningitis, the microscopic
examination and cerebrospinal fluid culture were negative in 25 of
the 49 infected patients, so the POC tests were the only diagnostic
tests used to guide antibiotic treatment. With regard to enterovirus
meningitis, the mean length of the hospital stay decreased from
2.9162.31 days in 2005 to 1.4361.09 days from 2008 to 2010
(P=0.0009) within the subgroup of infected patients over 15 years
old (figure 3); no significant difference was highlighted within the
other age groups or the entire population.
Lastly, POC testing was performed in 8% of 66,810 patients
admitted to the emergency wards of the Ho ˆpital Nord in 2009.
These patients were immediately discharged 2.6 times more often
than patients tested with a conventional diagnostic procedure.
Discussion
Our work is a retrospective observational study that provides
preliminary data on the practical issues and challenges of a new
organizational process implemented at the ‘‘hospital’s doorstep’’.
POC-labs implemented inside emergency departments have been
previously described by Lee-Lewandrowski et al. [36], but they
studied the impact of chemical analyses on patient flow. In this
study, our attention was primarily focused on the Ho ˆpital Nord
POC-lab, which corresponds to the previously described model of
satellite laboratories [10,36,37]. It is important to stress that POC
testing did not substitute for any routine analysis, and it is obvious
that the experience was successful because a large demand
Figure 2. Kinetics of the diagnoses resulting from POC testing from 2008 to 2010. Left vertical axis: the number of positive results provided
for meningitis, gastrointestinal infections, obstetric infections and tropical fever. Right vertical axis: the number of positive results provided for
respiratory infections. Under the graph, the implementation of tests is indicated by arrows in chronological order. BP: B. pertussis; EV: enterovirus; HP:
H. pylori; IMN: infectious mononucleosis; MP: M. pneumoniae; NM: N. meningitidis; PCT: procalcitonin, Rota/adeno: rotavirus/adenovirus; RSV:
respiratory syncytial virus; SP: S. pneumoniae.
doi:10.1371/journal.pone.0022403.g002
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demand of laboratory tests is regulated by budgetary limits be-
cause chief physicians regularly inspect the benefits and expenses
made by their department. The demands for POC testing would
have certainly been reduced if unreasonable cost overrun had
been highlighted.
Our evaluation was inherently limited regarding the impact of
POC-labs on patient management. The actual value of care
achieved with the implementation of POC-labs should be mea-
sured in a cost-effectiveness study, by assessing in a controlled
manner the patient outcomes (measured by health recovery,
sequelae and recurrences) relative to the costs (related to the length
of hospital stay, additional testing, drug prescriptions and adverse
effects) in a model comparing a conventional and a POC-lab
driven diagnostic procedure.
However, a first comparative analysis was carried out between
the POC-driven and the routine diagnosis of enterovirus menin-
gitis. Enterovirus meningitis is a benign disease and does not
warrant hospitalization; the exception is for infections related to
the enterovirus 71 type, for which the prognosis may be different
when it involves the central nervous system [38]. When the 2000
outbreak in Marseilles was reported, the mean length of the
hospital stay of enterovirus-infected patients was 5.564.9 days [9].
Later, the implementation of PCR-based diagnosis as a routine
method correlated with a significant decrease of mean length of
hospitalization to 2.261.8 days during the 2005 outbreak [16].
The results from this study showed that mean length of the
hospital stay was reduced by 1.5 days within the subgroup of
infected patients over 15 years old. The fact that a significant
reduction was not achieved within the pediatric population could
be related to the lack of an observation unit in the pediatric
emergency wards. Actually, a mean delay time of four hours was
measured between the admission of children with enterovirus
meningitis and the reception of lumbar puncture in POC-labs
(data not shown). Therefore, the patients are already hospitalized
before the POC result is available, while an observation of a few
hours and symptomatic care should be conducted before these
patients are home-discharged.
The POC-lab strategy modified the management of contagious
diseases. Nosocomial transmission of contagious pathogens was
previously illustrated by outbreaks of influenza virus [17],
respiratory syncytial virus [18], Bordetella pertussis [19], rotavirus
[20] and Clostridium difficile [21]. In these situations, it is advisable
to consider every suspected patient as a potentially contagious
source, which leads either to unnecessary procedures and costs or
to the isolation of suspected patients until the delivery of test
results. These results may be delayed, leading to patient transfer
from one ward to another [17]. The POC-lab strategy allowed the
appropriate procedures to be performed with only short delays in
982 patients who presented at the emergency wards of the Ho ˆpital
Nord. During the initial phase of the A/H1N1 outbreak, the PCR-
based diagnosis implemented in June of 2009 allowed for rapid
triage (4–7 hours) of patients presenting with influenza-like illness
[15]. At the peak period, the burst of activity led to the removal of
H1N1 molecular tests from POC-labs. However, the extraction
step was still performed in POC-labs, and the core laboratory
provided a definite result within 10 to 24 hours. Moreover, ICT
could detect 57.7% of infected patients in less than two hours
Table 1. POC test results according to expected outcomes.
Outcome Test result n* Reference
Isolation for contagiousness Positive influenza detection 545 [15,17]
(A/H1N1) (335)
Positive RSV detection 320 [18]
Positive B. pertussis detection 14 [19]
Positive rotavirus/adenovirus detection 96 [20]
Positive C. difficile detection 7 [21]
Avoid unnecessary hospitalization Positive enterovirus detection 117 [9,16]
Avoid unnecessary treatment Positive RSV detection 320 [22]
Negative procalcitonin detection 294 [23]
Negative S. pyogenes detection 1,827 [24]
Infectious mononucleosis diagnosis 17 [25]
Positive enterovirus detection 117 [26]
Negative S. agalactiae detection 763 [13]
Dengue diagnosis 9 [27]
C. tetani antibodies 8 [28]
Replace empiric with documented treatment Positive A/H1N1 influenza detection 335 [15,29]
Presence of urinary pneumococcal antigens 10 [30]
Presence of urinary L. pneumophila antigens 9 [31]
Positive M. pneumoniae detection 21 [32]
Bacterial meningitis 13 [33]
HSV meningitis 1 [34]
Malaria 149 [35]
*Only test requests coming from the emergency wards of the Ho ˆpital Nord were considered. HSV: herpes simplex virus, RSV: respiratory syncitial virus.
doi:10.1371/journal.pone.0022403.t001
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strategy to prevent contagiousness and to aid in focused treatment
in outbreak situations.
Another issue was to prevent unjustified prescriptions. France
has been identified as one of the nations with the highest antibiotic
use, both in Europe and worldwide [41]. This concern was
reinforced by the fact that practitioners could not use waived tests,
such as the rapid detection of S. pyogenes in tonsillitis, because the
French government does not approve reimbursement. In this
study, we highlighted 3,347 opportunities to avoid unnecessary
antibiotic treatment in the emergency wards of the Ho ˆpital Nord,
including opportunities involving viral infections. Specifically,
these infections included respiratory syncytial virus, mononucle-
osis, enterovirus and dengue fever, along with negative S. pyogenes
and S. agalactiae detection. A procalcitonin assay was implemented
upon the request of emergency practitioners for the same purpose.
This is because low serum concentrations make a bacterial
infection unlikely in the context of community-acquired pneumo-
nia and allow doctors to withhold antibiotic treatment without
compromising patient care [42]. However, performing a quanti-
tative assay validated procalcitonin-guided antibiotic use. This
assay was able to detect lower values of procalcitonin than ICT
[43,44], particularly for values within the range of uncertainty
(0.25–0.5 mg/L), in which case a bacterial infection is possible
and antimicrobial treatment is advised [42]. Nevertheless, the
quantitative assay was also shown to be easily practicable at the
site of care [23].
Lastly, the POC-lab directed the choice of antimicrobial
therapy. In half of the bacterial meningitis cases, microscopic
examination of CSF and cultures were negative [33], partly due to
the prescription of third-generation cephalosporins before the
lumbar puncture was performed (data not shown). Consequently,
only an empiric treatment combining a third-generation cepha-
losporin and vancomycin is followed, with vancomycin prescribed
systematically in children [45] and recommended in adults when a
pneumococcal resistance to b-lactam is possible [46]. Testing in
POC-labs therefore might have avoided the prescription of
vancomycin for meningococcal meningitis and in certain cases of
pneumococcal meningitis. In the case of malaria, we previously
reported that two-thirds of the infected patients in Marseilles were
Comorian migrants and that P. falciparum was responsible for more
than 90% of these cases [47]. When microscopic evaluation in the
core laboratory is not available, rapid diagnostic tests are useful in
this population because they usually harbor a high level of
parasitemia [35].
We assume that clinical microbiology in the 21
st century will
focus on concerns regarding the real-time management of patients
by delivering results at the time of care. To our knowledge, this is
the first report in the field of clinical microbiology of a strategy
closely implemented into patient care. We could only provide
Figure 3. Differential length of the hospital stay of enterovirus-infected patients according to the diagnostic process. The molecular
diagnosis of enterovirus meningitis was performed by the core laboratory in 2005 (laboratory developed real-time PCR assay) and the POC-labs from
2008 to 2010 (GeneXpertH system). The length of stay of infected patients in 2005 was measured [16] and compared with that of infected patients
during the period from 2008 to 2010. Each symbol represents a patient with enterovirus meningitis. Statistical significance was defined as a p value
,0.05.
doi:10.1371/journal.pone.0022403.g003
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emerging concept that it is possible to make a diagnosis based
essentially on a molecular or immunochromatographic approach
that produces profound changes in patient care.
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